Throne Biotechnologies

Our purpose is to comprehensively reverse type 1 diabetes and autoimmune diseases through stem cell innovations.

[Throne Biotechnologies @ThroneBiotech]

We are honored to be one of the awardees of the "5 Best BioTech Companies to Watch" by The Silicon Review!

To support Throne on our journey, check out our equity Crowdfunding campaign: https://t.co/qBctJgPl4Q

[Throne Biotechnologies @ThroneBiotech]

Join us on our journey for the cure to type 1 diabetes and become a part-owner of Throne Biotechnologies — check out our Crowdfunding Campaign below!
https://t.co/qBctJgPl4Q

[Throne Biotechnologies @ThroneBiotech]

We're thrilled to announce that we have just launched our Crowdfunding campaign for phase 2 of our clinical trials for type 1 diabetes, alopecia areata, and other autoimmune diseases!

Here are the details:
https://t.co/QWtRHt0NjB

[Throne Biotechnologies @ThroneBiotech]

We are thrilled to welcome Dr. Theodore Mazzone, a renowned endocrinologist and scientist, as Throne's Chief Medical Officer! https://t.co/fB7Y0lHGc4

[Throne Biotechnologies @ThroneBiotech]

Dr. Yong Zhao talks about fundraising, the sustainability of Educator Therapy, and the future of Throne Biotechnologies with @LSciNation. Read the exclusive interview here: https://t.co/QuBg6LOeXj

[Throne Biotechnologies @ThroneBiotech]

FDA Approves Stem Cell Educator Therapy to Treat COVID-19 in new phase II clinical trial https://t.co/s82nJEPrlX via @YouTube

[Throne Biotechnologies @ThroneBiotech]

Which biopharma startups will compete at INVEST Pitch Perfect? AI and therapeutics for autoimmune diseases are among the myriad areas of interest for the finalists in the biopharma track scheduled for day two of the conference.

Here are the details — https://t.co/B6kzUeCqEB

[Throne Biotechnologies @ThroneBiotech]

Aaron was only 13 years old when he underwent the Stem Cell Educator Therapy clinical trials in 2018. Listen to him share his experience and what life looks like now — two and half years later!